Abstract We describe the rationale, development, and usability testing for an integrated e-learning tool and decision aid for parents facing decisions about genome-wide sequencing (GWS) for their children with a suspected genetic condition. The online tool, DECIDE, is designed to provide decisionsupport and to promote high quality decisions about undergoing GWS with or without return of optional incidental finding results. DECIDE works by integrating educational material with decision aids. Users may tailor their learning by controlling both the amount of information and its format -text and diagrams and/or short videos. The decision aid guides users to weigh the importance of various relevant factors in their own lives and circumstances. After considering the pros and cons of GWS and return of incidental findings, DECIDE summarizes the user's responses and apparent preferred choices. In a usability study of 16 parents who had already chosen GWS after conventional genetic counselling, all participants found DECIDE to be helpful. Many would have been satisfied to use it alone to guide their GWS decisions, but most would prefer to have the option of consulting a health care professional as well to aid their decision. Further testing is necessary to establish the effectiveness of using DECIDE as an adjunct to or instead of conventional pre-test genetic counselling for clinical genome-wide sequencing.
Introduction
Introduction of diagnostic genome-wide sequencing (GWS) has important implications for patients and families, genetic counselling (GC), and for the health care system. For patients and families, identifying a genetic cause ends the Bdiagnostic odyssey^ (Berg 2014) and may result in more effective management, help provide access to appropriate resources, guide a family's expectations, provide reproductive options, and improve quality of life (Lingen et al. 2015; Makela et al. 2009) . A diagnosis may also have financial implications for the out of pocket expense of the family by saving money and time spent seeking the diagnosis (Christensen et al. 2015; Genereaux et al. 2015) . On the other hand, GWS raises concerns such as privacy and insurability for some families (Li 2014; Stavropoulos et al. 2016; Tabor et al. 2012) . The possibility of discovering unintended genomic results, also called secondary or incidental findings (IF), raises personal, medical, health economic, and ethical issues that have been debated at length (Blackburn et al. 2015) and need to be considered in any decision regarding GWS.
For genetic counsellors, the impact of GWS includes the challenge of how best to deal with complex and potentially lengthy pre-test GC sessions (Bick and Dimmock 2011; Lewis et al. 2016; Tabor et al. 2012; Wynn 2015) that are the current standard of care to ensure that families understand the benefits, risks, uncertainties, and implications of this new technology. There are concerns about the availability of sufficient numbers of genetic counsellors for the increasing volume of genomic tests as well as about the substantial cost of these professional services. In response, the need for innovative models of counselling and alternatives to conventional approaches has been raised (Lewis et al. 2016; Wynn 2015; Yu et al. 2013; Yurkiewicz et al. 2014) .
Supporting Patients' Pre-Test Decision-Making for GWS
The goal of genetic counselling prior to any testing is to support informed and values-based decision-making by patients and families. Promoting a realistic understanding of the benefits and limitations of GWS is of particular concern in part because of the inflated perception of genomic technology held by many people (Bombard et al. 2014) . The current standard of care -one-on-one, usually face-to-face, genetic counselling -may not be effective for all families and is time-consuming (and, therefore, expensive) for both families and highlytrained providers. Decision-making is challenging in complex, abstract, and emotionally laden situations (Hartmann et al. 2013 ) particularly when patients are acutely ill (Li 2014) . Furthermore, conventional GC is often more difficult when patients have a lower level of education, face linguistic barriers, or are from a different culture than that of the counsellor (Browner et al. 2003; Vanstone et al. 2012 ). Conventional GC is usually providerdriven (Meiser et al. 2008) , and it can be difficult for concerned family members to attend in-person, as a result of employment or childcare responsibilities, or travel expense. Whereas telemedicine may be an acceptable alternative in some circumstances (Hilgart et al. 2012 ), it does not save GC time and does not circumvent many other challenges of in-person counselling.
Research in GC has shown that patients may have equal or better knowledge acquisition with interactive online tools in comparison to traditional methods of didactic delivery (Birch 2014; Meilleur and Littleton-Kearney 2009) . The ability to self-tailor content is likely to further users' engagement, which is key to learning (Clark and Mayer 2011) . Enabling users to control the amount of information presented, its level of complexity, the delivery medium (e.g., text, diagrams, or video), and the time and place of learning contribute to effectiveness of learning.
In other clinical contexts, online tools that integrate educational material with decision aids have been shown to be of clear benefit in promoting informed decisions that are consistent with an individual's values (Sheehan and Sherman 2012; Stacey et al. 2014) , resulting in more realistic understanding of benefits and risks and less decisional conflict and regret than patients making similar decisions without such tools (Stacey et al. 2014 ).
Pre-Test Decision Support Tools
Online, interactive pre-test decision support tools have been used successfully in other areas of healthcare and to support other kinds of genetic counselling, including for carrier testing (Castellani et al. 2011; Gason et al. 2004 ), breast cancer screening or risk reduction (Green et al. 2005; Rupert et al. 2013) , and prenatal testing (Kuppermann et al. 2009; Yee et al. 2014) .
Although patients in some studies are noted to prefer the emotional or psychological support of personal counselling over e-tool use (Green et al. 2001 (Green et al. , 2004 , there is no evidence of differences in clinical anxiety among e-tool users versus those having face-to-face counselling (Albada et al. 2011; Gason et al. 2004 ) although most studies do not present data from long-term follow-up. Where interactive decision support tools were used as an adjunct to counselling by healthcare professionals, studies report that shared decision-making is promoted (Rupert et al. 2013) and that in-person sessions require less time for basic education, permitting more time to be spent on more complex issues (Green et al. 2005 ) and the open-ended discussion that is thought to be beneficial in GC (Wynn 2015) .
Although videos and online education material for GWS exist, such as learninggenetics.org (Columbia University Medical Center, Division of Medical Genetics 2013), we are not aware of any other online interactive educational and integrated decision support tools for pre-test GWS counselling. However, BMy46,^an interactive website that includes direct interactions with genetic counsellors to interpret, assist and guide users is currently being studied to manage post-GWS results (Yu et al. 2013) , and NC NEXUS is a tool being developed to support GWS in newborn screening (Lewis et al. 2016 ).
The quality of decisions people make is influenced by the amount of unfamiliar information; by the order in which options, risks, and benefits are presented to them; and by perceptions of the importance of less common risks or benefits, which are often over-or underweighted in decision-making (Bansback et al. 2014) . In situations involving uncertainty on multiple issues, it may be exceptionally difficult to make adequate decisions (Viberg et al. 2015) . A number of strategies have been used in developing decision aids to empirically address these issues, most recently taking advantage of interactive computer programs to tailor the decision aid and educational material to the specific concerns or issues of each individual to promote high quality decisions.
We have developed an online integrated educational and interactive decision support tool for use as an adjunct to conventional pre-test GC or for when conventional GC is not available.
Method
Development of DECIDE DECIDE (Decision-aid & E-Counselling for Inherited Disorder Evaluation) was developed on a generic software platform for creating clinical decision aids that has previously been described in detail (Bansback et al. 2014) . We chose and developed the e-learning content based on the results from several research projects that included focus groups, interviews, and guidance from patients' families, genetics health professionals, elearning and decisional scientists, and a review of GWS genetic counselling literature (Bick and Dimmock 2011; Bollinger et al. 2012; Tabor et al. 2012; Williams et al. 2014) . Throughout development, we followed the steps of the International Patient Decision Aid Standards (IPDAS), an organization that has created recommendations for a systematic and transparent process of developing decision aids. We followed an expanded model described by Coulter and colleagues (Coulter et al. 2013) , and have described each step in greater detail in Supplemental Fig. 1 .
Beta Testing and Usability Testing of DECIDE
Informed consent was obtained from all participants included in the study. Prior to usability testing, the content, structure, and function of DECIDE were reviewed by thirteen individuals including geneticists, genetic counsellors, nurses, members of the general public, and parents of children with developmental delay or intellectual disability. The beta version was generally well understood and perceived as easy to use but testing resulted in some language clarification and some minor rearrangement of e-learning material prior to usability testing.
Usability testing was performed with 16 parents. Each had at least one child with intellectual disability, and the family had already chosen to have genome-wide sequencing (either whole exome or whole genome sequencing) after conventional GC. None of these families had been given the option of receiving IF when their GWS was done, and the educational materials and decision processes related to IF were therefore excluded from the version of DECIDE used in the usability study as required by our research ethics board. The 16 participants were given individual URL links to DECIDE and asked to consider what it would have been like to use DECIDE to make a choice about GWS for their child. Participants were given a true/false knowledge questionnaire administered by phone about 2 weeks before and 2 weeks after using DECIDE. Concepts tested include what is the genome; genomic variants (i.e. mutations), variants of unknown significance and IFs; the likelihood of obtaining a diagnosis; and the possible psychological implications of GWS (see Supplementary Data). After the second knowledge questionnaire, parents were interviewed regarding their opinions on DECIDE. The usability questions (see Supplementary Data) were based on the PEMAT tool (Shoemaker et al. 2014) , and administered by telephone at the same time as the second knowledge questionnaire. Open-ended comments were solicited to clarify all responses. Interviews were audio-recorded and transcribed.
Results

DECIDE Description
DECIDE is an integrated e-learning tool and decision aid developed to facilitate the supportive functions of a genetic counsellor through patient-centred education and enhanced decision-making, two of the key facets of the reciprocal engagement model of GC (Hartmann et al. 2013) . DECIDE enables users to work individually, as a couple or family, or with a relative or friend, allowing patients to make decisions in ways that they find most comfortable and supportive. DECIDE is available at users' convenience -at any time or place there is an internet connection. Users may stop and restart their session, and repeat sections if they wish to, enabling them to make GWS and IF decisions at their own speed. The flexible structure of DECIDE and its integration of educational materials with decision aids are summarized in Fig. 1 and Table 1. The version described assumes that patients are invited to make some decisions about incidental findings. The modular nature of DECIDE is such that additional decisions may be added. Alternatively, DECIDE may be used to support decisions about GWS in situations where patients are given no choices regarding IF.
Users may tailor their learning by controlling both the amount of information and its format. The decision aids help users to weigh the importance of various relevant factors in their own lives and circumstances. After considering the pros and cons of GWS or return of incidental findings, if offered, DECIDE summarizes the user's responses and apparent preferred choices, although users can change these choices if they wish. Table 2 provides an overview of issues about whether to have diagnostic GWS performed, and Table 3 lists the analogous issues regarding return of sample classes of IFs that may be considered via DECIDE.
Each e-learning topic is presented in a choice of two formats: a video of about 1 min per topic or an illustrated section of text with similar content (Fig. 2) . This basic text is aimed at about the grade 6 reading level. Complex terms are presented in red text (see Fig. 2 ) and have mouse-sensitive, hover-over definitions. In addition, optional links to more complex information are available for most topics. Numerical risk information is given in text (e.g. B25 out of 100 people^) as well as by a graphical illustration (Fig. 3) , an approach considered to be best practice (Peters et al. 2007 ) to communicate proportions.
Recognizing that patients may prefer to make their decision about having GWS independently from their decisions about return of IFs (Li et al. 2016) , DECIDE separates these decisions. In addition, because the benefits and consequences of IFs vary depending on the nature of the particular findings and because IFs may be handled differently by different labs and in different jurisdictions, DECIDE groups IFs into Bbins ( Berg et al. 2011) , and the user can make a separate decision regarding return of results for each IF bin. The IF bins are modular, and the provider can add or remove them from DECIDE, as needed, giving the tool flexibility across different health care systems.
Whereas the decision to choose or decline GWS for the proband is a single decision, trios are often sequenced because of their added diagnostic efficiency (Shashi et al. 2014) . This means that if the parents choose to have GWS sequencing for their child, GWS will also be performed on both of them. In most cases the parents are healthy, so GWS is of no direct diagnostic benefit to them, but they are just as likely as their affected child to have IFs. DECIDE permits each parent to make separate decisions regarding return of IFs for herself or himself and a joint decision regarding return of IFs for their child. For example, in a study where the proband is a child, the parents may be able to choose return or non-return of three classes of incidental findings for their child:
& conditions usually occurring in childhood for which effective treatment is available; & conditions usually occurring in childhood for which effective treatment is not available; & adult-onset conditions for which effective treatment is available and two different classes of incidental findings for themselves:
& adult-onset conditions for which effective treatment is available; & adult-onset conditions for which effective treatment is not available.
In other instances, DECIDE may provide an opportunity to make a decision about pharmacogenomics incidental findings or carrier status for recessive diseases. Alternatively, in some circumstances, information may be provided but no decision is needed -e.g., in some jurisdictions, findings indicative of serious childhood disorders for which effective preventive interventions are available must be returned regardless of parent preference (Zawati et al. 2014) .
The goal of decision aids is to help the user weigh the importance of each issue relative to the othershence making the trade-offs that are thought to promote higher quality decisions. Each issue is presented in summary form (Fig. 3) with the option of expanding material to learn more about the issue. In the expanded version, parents' quotes are presented to illustrate the pros and cons of each issue. These quotes are from previous research by our group (Li 2014; Makela et al. 2009; Townsend et al. 2012) and are designed to provide different perspectives and to be thought-provoking. Box 1 provides an example of parents' quotations regarding Fig. 1 Outline of the DECIDE decision aid. Arrows indicate the usual progression, however users can return to previous decisions or steps to review or change their choices. The tool can be customized to allow decisions about various types of incidental findings after the initial decision about GWS Issues to consider when making this decision (see Table 2 Issues to consider when making this decision (see Table 3 for a list of issues) Text Table 2 Issues that may be considered through DECIDE when making decisions about whether to have GWS. In DECIDE, each issue has a button that opens to provide more detailed description -an example of the more detailed description for the issue BManagement^is shown in Fig. 3 Issue Brief description provided to users Knowledge A diagnosis can give an answer to families about the cause of their child's condition. Resources/Support A diagnosis can sometimes make it easier to get services like special help at school, extra care-givers, or access to support groups.
Insurability
Life insurance, disability insurance, and extended health insurance companies can sometimes charge higher fees or refuse coverage depending on the results. Explanation Some people believe that having a diagnosis can provide a way to explain the child's condition to family, friends, caregivers, and teachers. Reproductive Planning A diagnosis for your child may help you to know the chance that you will have another child with the same condition. Sometimes it is also helpful to share genetic information with extended family to help them make decisions about their own health and future planning. Management A diagnosis could, in a small number of cases, lead to a better treatment to help your child's symptoms.
Empowerment
Some families feel that knowing the diagnosis gives them a sense of control and helps them get on with planning and taking care of their child. Grieving/Acceptance Some families feel that a diagnosis helps them move through the grieving process and facilitates earlier acceptance of the child's life-long problem.
Advancing Medical Science Sometimes new information and knowledge from this testing might not help your child but might help doctors understand the condition and help other families in the future.
Decreasing Self-Blame Some parents feel that they may have somehow caused or been responsible for their child's problems, and finding a genetic cause can help relieve that self-blame for some people.
Result Regret Getting a diagnosis could result in some negative feelings for some people, including worry about the future, guilt that they passed on the condition, or hopelessness if the child won't get better. Avoiding BLabels^Getting a diagnosis can make some parents feel like their child will be judged by others based on a label rather than their child's own abilities. Cost to the Medical System Some people feel that the benefits of testing are likely to be small and that it is not worth the cost to the health care system. the importance of knowledge of the diagnosis in deciding whether to have GWS.
Box 1. An example of contrasting quotations from parents regarding the importance of knowledge of the genetic diagnosis in deciding whether to have GWS. From a parent who felt that knowledge of the diagnosis was important for their family: BIt was frustrating and frightening when we could see that there was a problem but no one could tell us what it was. Now we know.F rom parents who did not feel that knowledge of the diagnosis was important to them: BThe diagnosis is not an oasis in the desert that, ok, you have arrived. My false hope was that the diagnosis would say, 'Ok, he is this, and that is why he is this, and this is what you do,' but the funny thing is that the only thing that made me understand him was going along the path with him.B We just accepted the fact that it was unexplained and that this is the way he is.^F or each decision considered within DECIDE, the software visualizes each issue that the user indicates as important as a pie slice, and the sum of all issues as the pie (Fig. 4) . Users allocate a size for each pie slice (issue) corresponding to its importance to them in comparison to all of the other issues. Increasing the magnitude of one issue (enlarging one pie slice) necessarily decreases the size of all other issues (the other pie slices) because the size of the total pie is fixed. This approach helps avoid both information overload and over-weighting of less important concerns (Bansback et al. 2014) . A logical course of action implied by the combination of issues and their weights is then suggested to the user by DECIDE as a default option. Although the user can choose a diff eren t o ption if she p refers, this ap proa ch Bnudges^her towards a logical choice based on the concerns she identifies and further focuses her For some people just having knowledge for its own sake is important and gives them a sense of control.
Support from Others
Some people like to speak to others who are in a similar situation or join support groups to share their anxieties, positive experiences, and advice. Result Regret Some people worry that once they have had the testing and chosen which results to get, they may regret receiving the results after all.
Helping Family
Sometimes it is helpful to share genetic information about Incidental Findings with extended family to help them make decisions about their own health and future planning.
Advancing Medical Science
Sometimes new information and knowledge from this testing might not help your child but might help doctors understand the condition and help other families in the future. Autonomy of the Child Some people feel that their child should be able to make their own decision about receiving Incidental Findings for conditions that occur in adulthood. (This issue is not relevant for adults ' decisions) attention and engagement toward the decision (Bansback et al. 2014) .
DECIDE concludes by summarizing the user's decision and the issues chosen as important. This is followed by four basic multiple choice questions (with answers) designed for users to reflect on their own understanding and flag gross misunderstandings, and the four item SURE questionnaire (Légaré et al. 2010 ), a validated screening tool for decisional conflict.
Evaluation of DECIDE: Knowledge Acquisition
Sixteen parents from nine families (8 men and 8 women) participated in the usability study. They were parents of 2 girls and 7 boys (aged 2-16 years) who had undergone GWS after conventional genetic counselling. Parents were predominantly college/ university educated (13/16) and ranged in age from their 30's to 50's. Families live throughout British Columbia, and three live more than a 4 h drive from Vancouver -the location of the only tertiary care children's hospital in the province. These parents had received conventional GC prior to their families' GWS, therefore we anticipated their knowledge level would be high and unlikely to increase much after DECIDE use. Their responses on the knowledge questionnaire averaged 76 % correct before, and 86 % after using DECIDE, a difference that is not statistically significantly different. However, there were six questions that almost all users scored correctly and two questions (Q10 and Q13, Supplementary Material) that almost no users answered correctly, either before or after using DECIDE.
Evaluation of DECIDE: Utility
Almost all participants responded favourably or very favourably to most questions about DECIDE's ease of use, navigability, and acceptability. All users found the videos, graphics, and text easy to understand, with clearly defined medical terms. Questions were asked about the ease of choosing issues that were important to them (see Tables 2 and 3) , and of using the pie chart to compare the importance to them of various issues (Fig. 4) . All 16 participants found the pie chart easy and intuitive to use. However assigning a relative weight to the issues was challenging for four people but was also seen as beneficial: BIt forced me to really think long and hard about my biggest issues.^Only one person wanted additional information that DECIDE did not All 16 participants said that they would want to use DECIDE for GWS decisions, found it useful in their own situation, and all would recommend DECIDE to other families in the same situation. However, 15 of 16 participants said that ideally they would like to have the option of also having a consultation with a genetic counsellor. Box 2 provides some representative comments about DECIDE from users.
Discussion
Whereas there is good evidence that decision support tools increase users' engagement, improve knowledge, and encourage values-based, high quality decisions in many areas of health care (Stacey et al. 2014) , there has been little research on effectiveness and acceptability of decision aids and elearning to help support patients' testing decisions in genomics. We describe our development of the first interactive tool that explicitly integrates patients' goals and values to support pre-test GWS decisions, and present preliminary evidence that supports its clinical value.
Our data suggest that DECIDE is acceptable to patients, or at least to participants who are typical of those volunteering for research studies: tending to be well educated, fluent in Fig. 3 Example of more detailed information provided for the issue BManagement.^The abbreviated information (top line) says: BA diagnosis could, in a small number of cases, lead to a better treatment to help your child's symptoms.^The page is shown with the detailed information (below the Bclick here^statement) expanded for this issue. Below the graphic are quotes from parents in similar situations, intended to show pros and cons for receiving a diagnosis for the issue BManagement.D English, motivated and interested in research. We do not know how DECIDE would be perceived by different populations or whether there are some people or circumstances where it would not be acceptable.
The necessity of an internet connection is an obvious limitation, as is an understanding of English, although the content could be translated into other languages without having to change any functional aspect of the software. Despite the low literacy level of DECIDE's written information, the inclusion of simple explanatory diagrams, and the availability of parallel material in a video format, DECIDE may not be suitable for families with low literacy or limited education. However this group may also fair less well receiving verbal information from a health care provider if they have generally low health literacy and are less able to have a dialogue with the provider (Lea et al. 2011 ). We do not know how users' health literacy influences the effectiveness of decision support tools. Additional research with broader demographic representation is required to answer these questions.
There are many other areas that require further investigation as well. Other studies involving decision support tools have shown a correlation between total number of web pages viewed or total time spent on the web site and knowledge gained (Joseph-Williams et al. 2010 ). We did not measure this, nor did we attempt to identify how much time was spent on various parts of DECIDE. Furthermore, in order to measure knowledge gained, counselling-naïve patients will need to be studied, using rigorously validated knowledge acquisition methods, for both conventionally counselled patients and DECIDE users.
The time spent on the version of DECIDE used in this study varied from about 10 to 45 min, as reported by participants, but this did not include decisions about return of incidental findings, which was not offered in the sequencing studies from which these participants were recruited. Study of the time use and utility of each component and feature of DECIDE is needed to maximize its effectiveness. We do not know what is a realistic expectation of time commitment for this tool and others have observed that there is a narrow Bwindow of opportunity for information transfer to support decision making^ (Joseph-Williams et al. 2010) . The option to sign on and off to DECIDE at the user's convenience and the ability to make decisions about IF at a different time from the decision to proceed with diagnostic GWS may be important factors in promoting user engagement with DECIDE.
If DECIDE is used as an adjunct to GC appointments, it will be useful and cost-effective if it either reduces the time spent with the genetic counsellors or improves the quality of the GC session by requiring less time to convey factual information and more time to address more complex or personal issues and engage in shared decision-making.
An issue that may emerge after either conventional GC or via DECIDE is that of non-congruence in parents' choices regarding their child's testing. This could relate to choice of GWS and/or receipt of IF results. We wonder if this could be a greater issue in DECIDE users because the tool facilitates involvement by both parents, whereas for in-person counselling, there may be a tendency to assume that parents consulted with each other if only one parent is present at an in-person appointment. Regardless of counselling mode, our suggestion is that if parents cannot agree, after time and counselling support, then the involvement of a medical ethicist or other counsel may be necessary, especially if the need for GWS sequencing is medically urgent.
The positive responses received from our preliminary usability study support the acceptability and potential clinical value of DECIDE for a pre-test genomic applications. However, the 16 parents in this study represent a small and select group who had already received conventional genetic counselling and had chosen to have GWS for their family. We did not test DECIDE on people who declined GWS. All these factors limit the generalizability of our findings. In order to Fig. 4 Interactive tool used to weigh relative importance of various issues. Moving the sliders changes the size of the pie slices assess DECIDE's effectiveness, we are continuing to develop and improve DECIDE and are performing randomized clinical trials of its utility and cost-effectiveness in several clinical contexts, including where families have some IF choices. We are assessing change in users' knowledge using a reliable and validated tool, but are also measuring psychological attributes such as decisional conflict and anxiety. In doing so, we hope to determine DECIDE's clinical utility as an adjunct to, or in some circumstances, as a substitute for some functions of genetic counselling.
A current generic demonstration version of DECIDE, without specific IF bin modules, is available online at http://bit.ly/ DECIDE-GWS, and we welcome requests to use, test, and customize this software.
